Golden State Equity Partners Kintara Therapeutics, Inc. Transaction History

Golden State Equity Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.51 - $1.04 $32,752 - $66,788	-64,220 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.82 - $2.3 $5,822 - $16,329	-7,100 Reduced 9.96%	64,220 $55,000
Q2 2021 Aug 12, 2021	BUY	$1.26 - $2.4 $89,863 - $171,168	71,320 New	71,320 $162,000
Q1 2021 May 13, 2021	SELL	$1.32 - $2.74 $14,520 - $30,140	-11,000 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$1.26 - $1.72 $13,860 - $18,920	11,000 New	11,000 $14,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.